NZ Agency Latest To Warn Of Hepatitis C Drug Interaction With Warfarin
Executive Summary
The New Zealand medicines agency says it is working with drug manufacturers on a warning that using direct-acting antivirals in hepatitis C patients taking warfarin can cause changes in the blood coagulation measure, the INR.